1. Home
  2. SNDX vs LMB Comparison

SNDX vs LMB Comparison

Compare SNDX & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • LMB
  • Stock Information
  • Founded
  • SNDX 2005
  • LMB 1901
  • Country
  • SNDX United States
  • LMB United States
  • Employees
  • SNDX N/A
  • LMB N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • LMB Engineering & Construction
  • Sector
  • SNDX Health Care
  • LMB Consumer Discretionary
  • Exchange
  • SNDX Nasdaq
  • LMB Nasdaq
  • Market Cap
  • SNDX 1.1B
  • LMB 1.1B
  • IPO Year
  • SNDX 2016
  • LMB 2014
  • Fundamental
  • Price
  • SNDX $14.25
  • LMB $102.44
  • Analyst Decision
  • SNDX Strong Buy
  • LMB Strong Buy
  • Analyst Count
  • SNDX 10
  • LMB 2
  • Target Price
  • SNDX $36.20
  • LMB $110.00
  • AVG Volume (30 Days)
  • SNDX 2.0M
  • LMB 188.0K
  • Earning Date
  • SNDX 02-25-2025
  • LMB 03-12-2025
  • Dividend Yield
  • SNDX N/A
  • LMB N/A
  • EPS Growth
  • SNDX N/A
  • LMB 29.01
  • EPS
  • SNDX N/A
  • LMB 2.18
  • Revenue
  • SNDX $16,000,000.00
  • LMB $517,822,000.00
  • Revenue This Year
  • SNDX N/A
  • LMB $2.59
  • Revenue Next Year
  • SNDX N/A
  • LMB $12.46
  • P/E Ratio
  • SNDX N/A
  • LMB $48.36
  • Revenue Growth
  • SNDX N/A
  • LMB 0.13
  • 52 Week Low
  • SNDX $12.06
  • LMB $38.03
  • 52 Week High
  • SNDX $25.34
  • LMB $107.00
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 53.82
  • LMB 59.40
  • Support Level
  • SNDX $13.40
  • LMB $97.48
  • Resistance Level
  • SNDX $13.16
  • LMB $105.72
  • Average True Range (ATR)
  • SNDX 0.70
  • LMB 6.48
  • MACD
  • SNDX 0.26
  • LMB 1.12
  • Stochastic Oscillator
  • SNDX 82.02
  • LMB 82.11

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.

Share on Social Networks: